People: Veronica M. DiCamillo, Senior Counsel

Veronica M. DiCamillo

Senior Counsel

New York
Direct: (212) 218-5258
0
Veronica DiCamillo is senior counsel in the Corporate Department of Seyfarth Shaw LLP’s New York office.  Ms. DiCamillo concentrates here practice on representing clients in mergers and acquisitions, private equity investments as well as securities law and corporate governance matters.  She advises and represents public and private companies, private equity funds and investment banks in a variety of  U.S. and cross-border acquisitions and dispositions, investments, joint ventures,  tender offers, spin-offs, venture capital financings and corporate reorganizations.  In addition, Ms. DiCamillo counsels clients on securities law compliance, corporate governance and other general corporate matters.
 
Ms. DiCamillo’s practice is broad-based and she has represented clients across a wide variety of industries, including technology services, pharmaceuticals and healthcare, manufacturing, consumer goods and retail, media and entertainment and shipping.
 
Ms. DiCamillo’s experience includes the following transactions:
  • Pfizer Inc. in its $11.9 billion divestiture of its infant nutrition business to Nestlé S.A. and its global separation and spin-off of its animal health business, which is now Zoetis. 
  • Wasserstein & Co. in connection with its sale of Recorded Books to Shamrock Capital advisors LLC.
  • Verint Systems Inc. in several acquisitions, including its purchase of Contact Solutions and the Telligent business.
  • Valeant Pharmaceuticals International, Inc. in its $440 million acquisition of Obagi Medical Products through a tender offer.
  • Goode Partners in its acquisition of a minority interest in Incipio, a designer of mobile device accessories and technology.
  • Viacom Inc. in the sale of several of its digital gaming assets, including Shockwave and Addiciting Games, to Defy Media in return for a minority stake. 
  • Wabtec Corporation in the acquisition of approximately 51 percent of the share capital of Faiveley Transport S.A., a global supplier of high added value integrated systems for the railway industry, for $1.8 billion.
  • Representation of  a steering committee of first lien lenders in the RCS Capital Corp. Chapter 11 cases filed in the U.S. Bankruptcy Court for the District of Delaware.
  • Travelzoo in a reverse forward stock split.
  • Tranzyme Pharma in its merger with Ocera Therapeutics and related Nasdaq listing.
  • Greenbriar Equity Group in the sale of GWP Holdings, the parent company of Western Peterbuilt and Western Truck Parts & Equipment Co., to Dobbs Management Services.
While a junior associate, Ms. DiCamillo completed a secondment at UBS Investment Bank.  In addition, Ms. DiCamillo actively engages in pro bono work, focusing on counseling non-profits on various legal issues and representing individual clients in asylum cases.
 
Prior to graduating law school, Ms. DiCamillo served as a member of Fordham Law Review and interned with Judge Shira Sheindlin in the U.S. District Court, Southern District of New York.
Veronica DiCamillo is senior counsel in the Corporate Department of Seyfarth Shaw LLP’s New York office.  Ms. DiCamillo concentrates here practice on representing clients in mergers and acquisitions, private equity investments as well as securities law and corporate governance matters.  She advises and represents public and private companies, private equity funds and investment banks in a variety of  U.S. and cross-border acquisitions and dispositions, investments, joint ventures,  tender offers, spin-offs, venture capital financings and corporate reorganizations.  In addition, Ms. DiCamillo counsels clients on securities law compliance, corporate governance and other general corporate matters.
 
Ms. DiCamillo’s practice is broad-based and she has represented clients across a wide variety of industries, including technology services, pharmaceuticals and healthcare, manufacturing, consumer goods and retail, media and entertainment and shipping.
 
Ms. DiCamillo’s experience includes the following transactions:
  • Pfizer Inc. in its $11.9 billion divestiture of its infant nutrition business to Nestlé S.A. and its global separation and spin-off of its animal health business, which is now Zoetis. 
  • Wasserstein & Co. in connection with its sale of Recorded Books to Shamrock Capital advisors LLC.
  • Verint Systems Inc. in several acquisitions, including its purchase of Contact Solutions and the Telligent business.
  • Valeant Pharmaceuticals International, Inc. in its $440 million acquisition of Obagi Medical Products through a tender offer.
  • Goode Partners in its acquisition of a minority interest in Incipio, a designer of mobile device accessories and technology.
  • Viacom Inc. in the sale of several of its digital gaming assets, including Shockwave and Addiciting Games, to Defy Media in return for a minority stake. 
  • Wabtec Corporation in the acquisition of approximately 51 percent of the share capital of Faiveley Transport S.A., a global supplier of high added value integrated systems for the railway industry, for $1.8 billion.
  • Representation of  a steering committee of first lien lenders in the RCS Capital Corp. Chapter 11 cases filed in the U.S. Bankruptcy Court for the District of Delaware.
  • Travelzoo in a reverse forward stock split.
  • Tranzyme Pharma in its merger with Ocera Therapeutics and related Nasdaq listing.
  • Greenbriar Equity Group in the sale of GWP Holdings, the parent company of Western Peterbuilt and Western Truck Parts & Equipment Co., to Dobbs Management Services.
While a junior associate, Ms. DiCamillo completed a secondment at UBS Investment Bank.  In addition, Ms. DiCamillo actively engages in pro bono work, focusing on counseling non-profits on various legal issues and representing individual clients in asylum cases.
 
Prior to graduating law school, Ms. DiCamillo served as a member of Fordham Law Review and interned with Judge Shira Sheindlin in the U.S. District Court, Southern District of New York.

Education

  • J.D., Fordham University School of Law, Law Review (2007)

  • B.A., New York University Economics and Fine Arts, cum laude (2004)

Admissions

  • New York